0.68 - 0.75
0.33 - 0.86
12.91M / 4.66M (Avg.)
35.00 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-13.14%
Negative revenue growth while 0376.HK stands at 286.67%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-13.81%
Negative gross profit growth while 0376.HK is at 286.67%. Joel Greenblatt would examine cost competitiveness or demand decline.
0.61%
EBIT growth below 50% of 0376.HK's 41.17%. Michael Burry would suspect deeper competitive or cost structure issues.
0.61%
Operating income growth under 50% of 0376.HK's 49.54%. Michael Burry would be concerned about deeper cost or sales issues.
27.53%
Net income growth at 50-75% of 0376.HK's 39.76%. Martin Whitman would question fundamental disadvantages in expenses or demand.
-44.39%
Negative EPS growth while 0376.HK is at 36.54%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
3.34%
Diluted EPS growth under 50% of 0376.HK's 38.79%. Michael Burry would worry about an eroding competitive position or excessive dilution.
129.62%
Slight or no buybacks while 0376.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
23.43%
Slight or no buyback while 0376.HK is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-100.00%
Dividend reduction while 0376.HK stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
114.48%
OCF growth under 50% of 0376.HK's 301.22%. Michael Burry might suspect questionable revenue recognition or rising costs.
79.98%
FCF growth under 50% of 0376.HK's 294.47%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
31.83%
Positive 10Y revenue/share CAGR while 0376.HK is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
-55.08%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-50.53%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
305.97%
10Y OCF/share CAGR above 1.5x 0376.HK's 138.36%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-9.31%
Negative 5Y OCF/share CAGR while 0376.HK is at 148.69%. Joel Greenblatt would question the firm’s operational model or cost structure.
-66.91%
Negative 3Y OCF/share CAGR while 0376.HK stands at 186.15%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-34.65%
Negative 10Y net income/share CAGR while 0376.HK is at 91.38%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-33.96%
Negative 5Y net income/share CAGR while 0376.HK is 50.09%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
110.85%
Positive short-term CAGR while 0376.HK is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
-3.30%
Negative 5Y equity/share growth while 0376.HK is at 331.89%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-32.09%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while 0376.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
-55.41%
Firm’s AR is declining while 0376.HK shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
83.57%
Inventory growth of 83.57% while 0376.HK is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
-17.48%
Negative asset growth while 0376.HK invests at 6.22%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-51.38%
We have a declining book value while 0376.HK shows 2.16%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-83.12%
We’re deleveraging while 0376.HK stands at 1.53%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-18.82%
Our R&D shrinks while 0376.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-17.25%
We cut SG&A while 0376.HK invests at 90.35%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.